DUBLIN–(BUSINESS WIRE)–The “Digital Biomarkers Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product, Purpose of Solution, Type of Biomarker, Therapeutic Area, Business Model and Key Geographical Regions” report has been added to ResearchAndMarkets.com’s offering.
The global digital biomarkers market is estimated to grow from USD 5.6 billion in the current year to USD 35.8 billion by 2035, at a CAGR of 18.48% during the forecast period, to 2035.
In modern healthcare, digital biomarkers help enhance diagnostic and therapeutic precision by enabling continuous monitoring and evaluation of clinically relevant health parameters. As per the report published by the United Nations, the population aged 65 years and above is projected to double reaching close to 1.5 billion in 2050. Owing to the rise in the prevalence of chronic disorders and the aging population, the overall healthcare costs are likely to be increased substantially over the coming years. Studies have shown that continuous symptom tracking with early intervention offers various benefits, such as improvement in the quality of life of patients and reduced medical management burden.
Further, the growing number of virtual and decentralized clinical studies has spurred the adoption of digital biomarkers that provide accurate, reliable and real-time health information without the need for frequent in-person visits by the patients. This trend promotes the participation of a large number of patients in clinical studies, offers a more patient-centric approach, and provides a more diverse and elaborate dataset of biomarkers. Driven by the rising adoption of remote patient monitoring solutions (specifically during chronic indications) and preference for personalized treatments, the digital biomarkers market is likely to grow at a significant pace in the foreseeable future.
Digital Biomarkers Market: Key Insights
The report delves into the current state of the digital biomarkers market and identifies potential growth opportunities within the industry.
Some key findings from the report include:
- Presently, over 220 digital biomarker solutions are available / being developed by different players across the globe; of these, the majority of the solutions are data collection / analysis tools.
- Over 40% of digital solutions collect / analyze data related to various physiological biomarkers; most of these are used for real-time monitoring of adults and older adults.
- Several firms, with varying resources, have been actively involved in this domain; the majority of these firms are based in North America.
- Several industry as well as non-industry players have forged strategic deals in this domain; most of the intercontinental and intracontinental partnerships have been signed by players based in North America.
- Foreseeing a lucrative potential within this domain, several firms have invested over USD 3 billion (across over 160 funding instances), since 2015; notably, majority of the funds were raised for developing imaging biomarkers.
- In the past three years, over 50 events have been held to discuss the ongoing innovation and clinical outcomes in the digital biomarkers’ domain; further, around 55 eminent stakeholders have participated in these events.
- Since 2019, over 750 patents related to digital biomarkers have been filed / granted to various stakeholders to protect the intellectual property generated within this domain.
- The digital biomarkers market is anticipated to grow at an annualized rate (CAGR) of 18.5%, till 2035; the projected opportunity is likely to be distributed across different types of products, purposes of solutions and types of biomarkers.
Digital Biomarkers Market: Key Segments
Wearables Segment Occupies the Largest Share of the Digital Biomarkers Market
Based on the type of product, the market is segmented into software / applications, wearables, sensors and gaming solutions. At present, the wearables segment holds the maximum share of the digital biomarkers market. This can be attributed to the shifting preference of patients towards virtual consultations and telemedicine, and the growing prevalence of neurodegenerative disorders which in turn, has led to higher adoption of wearable digital biomarker solutions. It is worth highlighting that the digital biomarkers market for sensors is likely to grow at a relatively higher CAGR in the coming decade.
Monitoring Segment is Likely to Dominate the Digital Biomarkers Market During the Forecast Period
Based on the purpose of solution, the market is segmented into diagnosis, early detection, monitoring, and predictive insights. Currently, monitoring segment holds the maximum share of the digital biomarkers market. This can be attributed to the increasing prevalence of chronic disorders, which necessitates continuous tracking of health parameters of patients. It is worth noting that the digital biomarkers market for predictive insights is likely to grow at a relatively higher CAGR in the coming decade.
Physiological Biomarkers Occupy the Largest Share of the Digital Biomarkers Market
Based on the type of biomarker, the market is segmented into cognitive, idiosyncratic, physiological, vocal and other biomarkers. At present, the digital biomarker solutions that capture physiological biomarkers hold the maximum share of the digital biomarkers market. This can be attributed to high clinical validation of such biomarkers, compared to the other types of biomarkers, such as cognitive, idiosyncratic and vocal biomarkers. It is worth highlighting that the digital biomarkers market for vocal digital biomarkers is likely to grow at a relatively higher CAGR in the coming decade.
Neurological Disorders Account for the Largest Share of the Digital Biomarkers Market
Based on the therapeutic areas, the market is segmented into autoimmune disorders, cardiovascular disorders, infectious diseases, mental health disorders, neurological disorders, respiratory disorders, substance abuse disorders and other disorders. While neurological disorders account for a relatively higher market share, it is worth highlighting that the autoimmune disorders and substance abuse disorders segment is expected to witness substantial market growth in the coming years.
B2C Business Model Occupies the Largest Share of the Digital Biomarkers Market
Based on the business model, the market is segmented into B2B and B2C. At present, majority of the revenue is generated through the B2C business model. However, this trend is likely to evolve during the forecasted period, as developers are increasingly adopting B2B business models in order to maintain sustained growth.
North America Accounts for the Largest Share of the Market
Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Rest of the world. The majority share is expected to be captured by players based in North America. It is worth highlighting that, over the years, the market in Asia-Pacific is expected to grow at a higher CAGR.
Key Players in the Digital Biomarkers Market, Profiled in the Report Include:
- Acculi Labs
- ActiGraph
- AliveCor
- ATCOR
- BACtrack
- Biogen
- BioSerenity
- BioSensics
- Eyenuk
- Empatica
- Feel Therapeutics
- icometrix
- iMediSync
- IXICO
- Kinsa
- Koneksa Health
- Kontigo Care
- Progentec Diagnostics
- Quibim
- Vocalis Health
Digital Biomarkers Market: Research Coverage
- Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the digital biomarkers market, focusing on key market segments, including type of product, purpose of solution, type of biomarker, therapeutic area, business model and key geographical regions.
- Market Landscape: A comprehensive evaluation of digital biomarker solutions, considering various parameters, such as type of product, type of digital biomarker solution, type of biomarker, status of development, purpose of biomarker, target therapeutic area, target population, type of end-user, clinical validation of biomarker solution and AI integration within biomarker solution. In addition, the chapter includes a detailed analysis of digital biomarkers developers, along with information on their year of establishment, company size, location of headquarters, type of business model and most active players.
- Product Competitiveness Analysis: A comprehensive competitive analysis of digital biomarker solutions, examining factors, such as developer strength, product competitiveness and status of development.
- Company Profiles: In-depth profiles of key digital biomarkers developers, focusing on company overviews, financial information, digital biomarker portfolio, recent developments and an informed future outlook.
- Partnerships and Collaborations: An analysis of partnerships established in this sector based on several parameters, such as year of partnership, type of partnership, type of biomarker, target therapeutic area, type of partner and most active players. This section also highlights the regional distribution of partnership activity in this market.
- Funding and Investment Analysis: A detailed evaluation of the investments made in this domain based on several parameters, such as year of funding, type of funding, amount invested, type of biomarker, therapeutic area, most active players, most active investors and regional distribution of funding.
- Global Events Analysis: A detailed analysis of global events attended by the companies in the digital biomarkers industry, based on relevant parameters such as year of event, type of event, event platform, event organizer, location of event, and most active players, speakers and designations
- Patent Analysis: Detailed analysis of various patents filed / granted related to digital biomarkers based on type of patent, publication year, application year, patent jurisdiction, cooperative patent classification (CPC) symbols, type of applicant and most active players. It also includes a patent benchmarking analysis and a detailed valuation analysis.
- Big Pharma Analysis: A comprehensive examination of various initiatives focused on digital biomarkers undertaken by major pharmaceutical companies. This analysis various initiatives, such as number of clinical trials, number of collaborations, number of conferences attended, number of funding instances, and number of publications.
- Market Impact Analysis: The report analyzes various factors such as drivers, restraints, opportunities, and challenges affecting market growth.
Reasons to Buy this Report
- The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
- Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
- The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
Additional Benefits
- Complimentary PPT Insights Packs
- Complimentary Excel Data Packs for all Analytical Modules in the Report
- 10% Free Content Customization
- Detailed Report Walkthrough Session with Research Team
For more information about this report visit https://www.researchandmarkets.com/r/mgdqvp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900